eXoZymes领导人加入BioMADE委员会来制定美国无细胞生物制造战略。 eXoZymes leaders join BioMADE committees to shape U.S. cell-free biomanufacturing strategy.

eXoZymes Inc.宣布,高级领导人Damien Perriman和Paul Opgenorth博士已当选为BioMADE治理委员会的领导职务,推动该公司对无细胞生物制造的影响。 eXoZymes Inc. announced that senior leaders Damien Perriman and Dr. Paul Opgenorth have been elected to leadership roles within BioMADE’s Governance Committees, advancing the company’s influence in cell-free biomanufacturing. 领导委员会和技术委员会的作用使eXoZymes能够帮助制定国家技术路线图,支持美国工业复原力,促进可持续生产药品、生物燃料和化学品。 The roles on the Leadership Council and Technical Committee allow eXoZymes to help shape national technology roadmaps, support U.S. industrial resilience, and promote sustainable production of medicines, biofuels, and chemicals. 该公司的人工智能工程外酶能够在活细胞外发生化学反应，为石化工艺提供可扩展、环保的替代方案。 The company’s AI-engineered exozymes enable chemical reactions outside living cells, offering a scalable, eco-friendly alternative to petrochemical processes. 它们参与FIRE和BioMADE4.0等倡议,强调努力加强国内生物制造和供应链的独立性。 Their participation in initiatives like CFIRE and BioMADE 4.0 underscores efforts to strengthen domestic biomanufacturing and supply chain independence.